Default company panoramic image

Genprex, Inc.

Research that Makes a Difference in the Lives of Cancer Patients. Providing new solutions to solve today’s problems in fighting cancer.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Austin, TX, USA
  • Currency USD
  • Founded November 2009
  • Employees 5
  • Website

Company Summary

Genprex is a privately held, clinical-stage biopharmaceutical company developing nanomolecular therapies that control universal cancer pathways to unlock the unrealized potential of a variety of targeted cancer therapies. Our tumor suppressors are pan-kinase inhibitors that work to induce apoptosis in cancer cells and control cell signaling and inflammatory pathways. Our drugs are used in combination with other targeted cancer therapies.


  • Default avatar
    Jack Roth
    Chair, Scientific and Medical Advisory Board

    Jack A. Roth, MD, FACS, an internationally renowned cancer expert and oncology pioneer, is Professor and Distinguished Chair of Thoracic Surgery, Professor of Molecular & Cellular Oncology, Director of the Keck Center for Innovative Cancer Therapies, and Chief of Section of Thoracic Molecular Oncology at The University of Texas MD Anderson Cancer Center (UTMDACC).

    Dr. Roth is a prolific inventor and author with more than 500 peer reviewed pub